, and the Generic and Moderate Preterm Subcommittees of the NICHD Neonatal Research Network* Objective To evaluate the temperature distribution among moderately preterm (MPT, 29-33 weeks) and extremely preterm (EPT, <29 weeks) infants upon neonatal intensive care unit (NICU) admission in 2012-2013, the change in admission temperature distribution for EPT infants between 2002-2003 and 2012-2013, and associations between admission temperature and mortality and morbidity for both MPT and EPT infants. Results MPT and EPT cohorts consisted of 5818 and 3213 infants, respectively. The distribution of admission temperatures differed between the MPT vs EPT (P < .01), including the percentage <36.5°C (38.6% vs 40.9%), 36.5°C-37.5°C (57.3% vs 52.9%), and >37.5°C (4.2% vs 6.2%). For EPT infants in 2012 compared with 2002, the percentage of temperatures between 36.5°C and 37.5°C more than doubled and the percentage of temperatures >37.5°C more than tripled. Admission temperature was inversely associated with in-hospital mortality.
1 Low admission temperatures were common (46.9% were <36.0°C) and were inversely associated with the risks of mortality and late-onset sepsis. Multiple randomized trials, primarily in extremely preterm (EPT) neonates, have tested interventions to reduce the proportion of infants admitted to neonatal intensive care units (NICUs) with low temperatures. Interventions tested included polyethylene wraps, 2 exothermic mattresses, 3, 4 polyethylene caps, 5 active warming during cesarean delivery, 6 increased delivery room temperature, 7 and humidified and heated air during stabilization. 8 Evidence-based interventions to prevent low temperatures at birth are now part of neonatal resuscitation. 9 Quality improvement initiatives demonstrated a reduced proportion of preterm infants with low temperatures upon NICU admission, [10] [11] [12] but elevated admission temperatures also have been reported among preterm infants who received interventions to prevent low temperatures. [13] [14] [15] [16] In view of the efforts to prevent hypothermia at birth, it is likely that the distribution of admission temperatures has changed compared with our earlier report. (29 0 -33 6 weeks of gestation) conducted by the NRN combined with a standing registry of mortality and morbidity for EPT infants, <29 weeks) facilitated examination of admission temperature over a broad gestational age range. The objectives of this report were to determine the frequency of low and high admission temperature among a recent cohort of MPT and EPT infants born in 2012 and 2013, the change in distribution of admission temperature among EPT infants compared with those born in 2002 and 2003, and associations between admission temperature and mortality and morbidity in both the MPT and EPT infant cohorts.
Methods
This study analyzed prospectively collected maternal and infant data abstracted from the medical record by trained research nurses at 18 centers of the Eunice Kennedy Shriver National Institute of Child Health and Human Development's NRN. Data were entered into a computerized database approved by the institutional review board at each participating site. Inclusion criteria were infants who were born at an NRN center and admitted directly to the NICU from a delivery or operating room with a gestational age between 22 0 and 33 6 weeks. Data were collected from March 1, 2012 through October 31, 2013 for MPT infants with gestational ages of 29 0 through 33 6 weeks (MPT) and throughout 2012 and 2013 for EPT infants with gestational ages of 22 0 through 28 6 weeks (EPT). Exclusion criteria included congenital brain malformations, malformations resulting in an open lesion (eg, myelomeningocele, abdominal wall defects), noninitiation of medical therapy for infants who died within 12 hours, a prenatal diagnosis with a decision to withdraw or limit intensive care, missing admission temperature measurements, and first temperature recorded at >2 hours of age.
The first temperature after NICU admission from Labor and Delivery was recorded as the admission temperature. For centers that admit infants to a holding area or delivery room stabilization area, the first temperature recorded in this area was recorded as the admission temperature. The date and time of the admission temperature and the site of temperature measurement (axilla, rectal, or skin) were recorded. Temperatures recorded in the delivery room or during transport to the NICU were not recorded. Use of a thermal wrap (NeoWrap [Fisher-Paykel Healthcare, Auckland, New Zealand] , or thin plastic food wrap) was collected if this information was available. The database does not contain information on any other intervention to maintain temperature at birth (eg, exothermic mattress, hat, etc).
Data for 2012-2013 included (1) maternal variables including maternal hypertension, multiple births, antenatal steroids, antibiotics; (2) intrapartum variables including chorioamnionitis (clinical and histologic), duration of rupture of membranes, and delivery mode; (3) infant characteristics including birth weight, gestational age (obstetric estimate), sex, race, and ethnicity; (4) delivery room events including intubation, chest compressions, medications, and Apgar scores; and (5) 18 Descriptive statistics characterized the distribution of admission temperatures among MPT and EPT infants. Statistical significance was calculated using c 2 tests and logistic regressions. Associations between admission temperature and neonatal outcomes were initially explored with bivariate analyses. Variables significant at the 0.10 level were entered into logistic regression models to adjust for covariates using admission temperature as a continuous variable. Variables included in the models were antenatal steroid exposure, sex, race, birth weight, intubation, Apgar at 5 minutes, center, prematurity level (MPT or EPT), and the interaction between admission temperature and type of infant (MPT/EPT) if present. Results were expressed using ORs and 95% CIs. The results prompted 2 posthoc analyses. Short-term outcomes of EPT infants with admission temperatures >37.5°C were explored with adjusted logistic regression for differences with infants whose admission temperature was 36.5°C-37.5°C or <36.5°C. The sample size was determined by the number of infants available in the database registries. With the available MPT and EPT infants in 2012-2013, the power was greater than 90% among both cohorts to detect a 10% reduction in the frequency of admission temperature less than 36.0°C based on 2002-2003 data.
In a sensitivity analysis, associations were evaluated between missing temperatures and mortality. Two logistic regression models adjusting for the above listed covariates were run: the first comparing mortality among MPT and EPT infants between those missing vs those not missing admission temperatures and a second model comparing mortality between the 4 categories of admission temperature (<36.5°C, 36.5°C-37.5°C, >37.5°C, and missing).
Results
During 2012-2013, a total of 10 965 infants were entered into the Moderate Preterm Database (7051 MPT) and Generic Database (3914 EPT) with gestational ages from 22 0 to 33 6 weeks. The final cohort included 9031 infants (5818 MPT and 3213 EPT) after excluding 705 (6.4%) outborn infants (637 MPT and 68 EPT), 405 (3.7%) infants with anomalies or limited care, and 824 (7.5%) infants with missing or late admission temperature recordings. Exclusions because of missing temperature or time of temperature recordings were similar for MPT THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 192 • January 2018
and EPT infants (7.1% and 9.6% of eligible infants, respectively). Table I shows characteristics of the MPT and EPT cohorts and their associated admission temperatures. The age of the admission temperature was earlier for MPT compared with EPT infants. The distribution of the temperature site (axillary, rectal, skin) used for admission temperature differed slightly; MPT had more rectal and fewer skin temperatures compared with EPT. Median and range of admission temperatures for MPT and EPT were similar, but the distribution differed. More MPT infants than EPT infants had admission temperatures 36.5°C-37.5°C, but fewer MPT infants had admission temperatures <36.5°C or >37.5°C. MPT infants with missing admission temperatures were similar with respect to the variables in Table I except for less use of maternal antibiotics (63.6%, P < .0001), more frequent 5-minute Apgar score <7 (15.9%, P < .001) and more frequent cardiopulmonary resuscitation (3.9%, P < .001). Deaths among MPT infants with admission temperatures (1.9%) did not differ from infants without an admission temperature (3.1%, P = .09). EPT infants with missing admission temperatures differed from those who had admission temperatures with less use of maternal antibiotics (68.9%, P = .0017) and antenatal steroids (86.6%, P = .003), lower birth weight (780 ± 240 g, P < .0001) and gestational age (25.3 ± 1.7, P < .0001), more frequent 5-minute Apgar scores <7 (59.8%, P < .0001), and more frequent cardiopulmonary resuscitation (24.5%, P < .0001). Deaths among EPT infants with admission temperatures (14.3%) differed from infants without an admission temperature (39.5%, P < .0001). Admission temperatures by 0.5°C strata are plotted in Figure 1 (available at www.jpeds.com). The relationship between gestational age and admission temperatures for MPT and EPT is shown in Table II (Figure 2) , the percentage of admission temperatures between 36.5°C and 37.5°C more than doubled in 2012-2013 and was mirrored by reductions in admission temperatures <36.5°C. In contrast, admission temperatures >37.5°C increased 3-fold (2.0%-6.1%). EPT infants evaluated in 2002-2003 were similar to those evaluated in 2012-2013 in birth weight (872 ± 233 g vs 858 ± 234 g), gestational age (26.0 ± 1.6 weeks vs 26.0 ± 1.6 weeks) and sex (53.8% vs 51.8% male) but had less frequent 5-minute Apgar <7 (39.0% vs 43.7%, P = .0015), and more frequent intubation at birth (73.8% vs 60.2%, P < .0001). Post-hoc analysis of EPT infants in 2012-2013 with admission temperatures >37.5°C compared with infants with admission temperatures of <36.5°C or 36.5°C-37.5°C indicated no differences in 1-and 5-minute Apgar score, frequency of cardiopulmonary resuscitation, mortality, severe ICH, highest respiratory support, early or lateonset sepsis, or NEC. EPT infants with an admission temperature <36.5°C or 36.5°C-37.5°C had lower odds of intubation (OR 0.54, 95% CI 0.36-0.82 and OR 0.65, 95% CI 0.44-0.96, respectively) compared with infants with an admission temperature >37.5°C adjusted for antenatal steroids, sex, race, and gestational age.
EPT infants had higher rates of mortality, respiratory support, severe ICH, early onset sepsis, late onset sepsis, and NEC than MPT infants (P < .01, Table III ). The acquisition of cranial ultrasounds differed between cohorts (56.4% MPT, 96% EPT). Adjusted associations between admission temperature and mortality and morbidities are summarized in Table III . Significant interactions between prematurity level (MPT/EPT) and admission temperature indicate that the association of admission temperature and a specific outcome varied for EPT and MPT infants; ORs are listed for each prematurity level. Over the range of admission temperatures in this study, the odds of mortality decreased for each 1°C increase in admission temperature (OR 0.81, CI 0.71-.91). The absence of an interaction with prematurity level indicated that this association 6 weeks born January 2012-December 2013. *Categorical data are presented as n (%) where percentages are calculated based on nonmissing data. Continuous data are presented as mean ± SD or median and range (admission temperature). P values for categorical data were calculated using chi-square and continuous data using the Wilcoxon test.
extended across gestational ages of 22 0 -33 6 weeks. Associations between admission temperature and respiratory support at 28 days, severe ICH, and early-onset sepsis were present only among MPT infants; the odds of each outcome increased for each 1°C increase in admission temperature. There was no association between admission temperature and either lateonset sepsis or NEC.
In a sensitivity analysis, mortality was higher among infants with missing admission temperatures compared with those with documented admission temperatures (P = .029). This association was present for EPT (OR 2.25 
Discussion
The principal findings of this study were that the distribution of admission temperatures differed between MPT and EPT infants born at 18 centers of the NRN in 2012-2013, the distribution of admission temperatures in EPT infants differed markedly compared with 10 years earlier in a subset of NRN centers, and that admission temperature was associated with the odds of important outcomes, most notably in-hospital mortality. 
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Although MPT and EPT infants had similar median admission temperatures, the distribution differed and EPT infants had fewer temperatures between 36.5°C and 37.5°C and more temperatures less than 36.5°C. This presumably reflects the higher ratio of body surface area to weight and other thermal disadvantages of EPT compared with MPT infants. A limitation of our study is the absence of data on interventions used at NRN sites to minimize heat loss. It is unclear if differences in temperature distribution between MPT and EPT reflect solely heat loss, measures to avoid heat loss or a combination of both. However, differences in temperature distribution among MPT and EPT are not striking, and both gestational age cohorts have a large percent of infants with admission temperatures <36.5°C. The distribution of admission temperatures is similar to data reported by the Canadian Neonatal Network for 9833 infants born at <33 weeks gestation between 2010 and 2012. 19 EPT infants in the current report had a higher frequency of elevated admission temperatures compared with MPT infants. This has been noted with implementation of placing EPT infants in plastic bags at birth [13] [14] [15] [16] and use of plastic bags combined with exothermic mattresses, 4 but has not been universally reported. For example, a multidisciplinary practice plan (occlusive wrap, exothermic mattress, caps, and increased room temperature) decreased low admission temperatures in preterm infants without an increase in temperatures >37.5°C. 20 We cannot distinguish whether the elevated temperatures among NRN EPT infants reflected interventions to avoid hypothermia or maternal conditions (eg, fever associated with chorioamnionitis or epidural analgesia). 21 In our prior report, 46.9% of infants with a birth weight <1500 g had an admission temperature <36.0°C.
1 Compared with EPT infants born in 2002-2003, EPT infants born in 2012-2013 had a dramatic shift in the distribution of their admission temperatures; fewer infants had lower temperatures but more had elevated temperatures. These changes presumably reflect a greater focus on avoiding low temperatures after birth by adopting strategies to attenuate heat loss. Term infants exposed to peripartum maternal pyrexia have higher rates of respiratory depression at birth, seizures, encephalopathy and cerebral palsy. [22] [23] [24] [25] Our post-hoc analyses suggest that elevated temperatures at birth among EPT infants are not associated with more frequent short-term morbidities, but the odds of intubation were higher among hyperthermic infants.
In the current study, an inverse relationship between admission temperature and in-hospital mortality was found, as previously reported. 1 Of note, the distribution of admission temperatures differed from infants born in 2002-2003. Multiple publications have reported a similar association. These include the EPICure study (infants <27 weeks' gestation), 26 the California Perinatal Quality Care Collaborative (infants with a birth weight <1500 g), 27 the Brazilian Network of Neonatal Research (23-33 weeks), 28 and the Canadian Neonatal Network. 19 Consistent with these observations is a systematic review of prediction models for mortality among preterm infants.
29 Among 59 studies (1998-2010), 8 variables predicted survival, including a normal temperature on admission. The association between admission temperature and mortality prompted a randomized trial of polyethylene wraps at birth to improve survival. Among infants 24 0 -27 6 weeks, wraps did not change mortality (aOR 0.9, 95% CI 0.6-1.3) between groups despite different baseline admission temperature (36.3°C vs 35.7°C, wrap vs no wrap, P < .0001).
16 Similar mortality between groups with different admission temperatures may reflect a relatively small, albeit significant difference of admission temperatures between groups. Whether a bundle of interventions to prevent hypothermia at birth would result in wider separation of admission temperatures between groups and alter mortality is unclear. Although mortality was similar between intervention groups, mortality rose with lower baseline temperatures and was most prominent at the extremes of temperature (<35.5°C). 16 The available data from Reilly et al as well as the results of our current and prior publication 1 do not distinguish whether temperature is causally linked with mortality or if temperature is simply a marker of mortality risk. 16 An association between admission temperature and lateonset sepsis was not found in the current study, in contrast to our prior findings. 1 Reductions in late-onset sepsis have been documented in the NRN as recently reported in an analysis of care practices, morbidity, and mortality over 20 years. 30 These results mirror quality initiatives to reduce nosocomial infection. 31, 32 For MPT infants, increasing admission temperature was associated with higher odds of respiratory support at 28 days, severe ICH, and early onset sepsis. We did not investigate bronchopulmonary dysplasia because of limitations in applying the same diagnostic criteria to MPT and EPT. Caution is needed when considering these findings given the low frequency of morbidities among MPT infants and that cranial ultrasound examinations were not routinely performed among MPT infants. These results differ from the Canadian Neonatal Network, which demonstrated a U-shaped relationship between admission temperature and individual morbidities for infants <33 weeks including severe neurologic injury, severe retinopathy of prematurity, NEC, bronchopulmonary dysplasia, nosocomial infection, and duration of ventilation.
19
There are limitations to this study. Data were not available on interventions to reduce heat loss at birth, maternal and delivery room temperatures, and use of epidural anesthesia. Data were missing for the admission temperature or the time of the temperature for both MPT and EPT infants, and some infants with missing admission temperatures differed in selected characteristics from those with available temperatures. The magnitude of the association between admission temperature and mortality may be underestimated given the higher mortality among infants with missing temperatures. Strengths of this study include a large sample size from a contemporary cohort of preterm infants, prospective data collection, and predefined morbidities.
Over the past 10 years, there has been a dramatic shift in the distribution of admission temperatures among EPT infants. There are more admission temperatures in the desired range, and fewer lower temperatures at a small cost of more frequent higher temperatures. In spite of the change in temperature distribution, approximately 40% of both EPT and MPT infants had admission temperatures <36.5°C, and lower admission temperatures were associated with in-hospital mortality. These data support ongoing surveillance of admission temperatures and quality improvement efforts to avoid hypothermia balanced with the potential for elevated temperatures upon NICU admission. ■ 29. Medlock S, Ravelli AC, Tamminga P, Mol BW, Abu-Hanna A. Prediction of mortality in very premature infants: a systematic review of prediction models. oth the drug laws of 1938 and 1962 were catalyzed by pediatric tragedies-the deaths from sulfanilamide elixir made with the untested but toxic diethylene glycol and the birth defects, particularly phocomelia, from maternal ingestion of thalidomide, respectively. The result was that drugs introduced after 1962 had to be tested in children or had to carry an "orphaning clause," stating it was not recommended for children. In 1968, Harry Shirkey, a pediatrician and pediatric pharmacologist, criticized the prevailing climate "created by present regulations of human experimentation [that] makes drug testing difficult" and urged all pediatricians and pediatric subspecialists to take on the "responsibility for developing active programs of clinical pharmacology and drug testing in infants and children" lest children become "therapeutic orphans." More than 25 years would pass before the National Institutes of Health would create the Pediatric Pharmacology Research Unit Network to support pharmaceutical testing of children (1994) . At that time, nearly 80% of drugs lacked a pediatric label.
1 Between 1997 and 2002 , new federal laws and regulations "increased both the number of medications in pediatric clinical trials and the number that are labeled for use in children." 2 The new drug testing was encouraged by both a carrot and a stick. 2 The carrot was the "pediatric exclusivity provision," which granted an additional 6 months of patent protection or market exclusivity for new molecular entitles voluntarily tested in children. The stick was the "Pediatric Rule," a requirement by the Food and Drug Administration that, in some circumstances, pharmaceutical companies would be required to test their molecular entitles to get approval from the Food and Drug Administration. Although this regulation was struck down, Congress passed other legislation. By 2002, new policies from the National Institutes of Health and Congressional regulations promoting pediatric research led Christensen and Chesney to proclaim that the "'Therapeutic Orphan' has finally been adopted."
1 The adoption was further solidified by the enactment of the Food and Drug Administration Safety and Innovation Act in 2012, which made these mandates permanent, although funding comes up for renewal every 5 years. 
